Empire Life Investments Inc. Exact Sciences Corp Transaction History
Empire Life Investments Inc.
- $1.49 Billion
- Q1 2025
A detailed history of Empire Life Investments Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Empire Life Investments Inc. holds 293,878 shares of EXAS stock, worth $15 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
293,878
Previous 242,765
21.05%
Holding current value
$15 Million
Previous $13.6 Million
6.74%
% of portfolio
0.85%
Previous 0.88%
Shares
24 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$913 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$903 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$640 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$617 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$338 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.06B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...